North Richland Hills

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Dermatomyositis and polymyositis (myositis)2 trials
• Asthma1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Completed1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• AstraZeneca2 trials
• Alexion Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

  NCT06455449· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Dermatomyositis and polymyositis (myositis)1 recruiting

Closed trials

• Terminated

  Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

  NCT04999020· Phase 2/3· Alexion Pharmaceuticals, Inc.· Source

• Completed

  Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

  NCT04609904· Phase 3· AstraZeneca· Source